Gamestop Corporation - Class A
NYSE: GME
$23.08
+$0.09 (+0.4%)
Closing Price on November 6, 2024
GME Articles
Meme stocks as a group traded lower Monday and were not seeing much action in Tuesday's premarket session.
Published:
One of the OG meme stocks made a sharp move higher last week, and a couple of analysts' ratings moved two more in different directions.
Published:
Why does a coronavirus vaccine maker's stock drop more than 20% after the vaccine is approved for use? It happened Wednesday.
Published:
Meme stocks were lagging along with the broad market, as we all wait to hear the results from the Fed's two-day meeting.
Published:
One of the original meme stocks traded up by as much as 80% after markets closed Tuesday, following a series of announcements that could have triggered a short squeeze.
Published:
Monday was also a good day for meme stocks. Will Tuesday be more of the same?
Published:
Meme stocks pretty much traded in lockstep with the broader market Monday, with advancers leading decliners by around 2 to 1.
Published:
The SEC on Monday released a report on market behavior surrounding the January meme stock runup that hiked shares of companies like GameStop and AMC into the stratosphere.
Published:
One stock that had its moment in the meme stock sun last January has been generating some chatter lately among some retail investors.
Published:
One of the hottest meme stocks of the past two weeks was giving back more of its gains Monday.
Published:
Two of what might be called the original meme stocks both outperformed the overall markets on Thursday, and another stock traded more than 1 billion shares on the day.
Published:
Seven meme stocks posted double-digit gains on Monday, with Camber Energy the day's big winner.
Published:
Investors with any sense of stock market history are well aware that’s it’s not a question of if but when a big market correction comes. One prescient analyst says it makes sense to take...
Published:
Thursday was mostly an up-day for meme stocks and Friday may be shaping up for more of the same.
Published:
Vaccine maker Moderna has announced it is working on a new vaccine, and another COVID-19 treatment is getting hammered.
Published: